Eli Lilly’s stock heads for biggest selloff since 2008 after sales of anti-obesity drugs Mounjaro and Zepbound came up well short of forecasts.
Source: MarketWatch
30. October 2024 13:35
Eli Lilly’s stock heads for biggest selloff since 2008 after sales of anti-obesity drugs Mounjaro and Zepbound came up well short of forecasts.
Source: MarketWatch